# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-016010
Filing Date
2025-04-28
Accepted
2025-04-28 16:02:59
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20042039x3_defa14a.htm | DEFA14A | 6736
2 |  | ny20042039x3_nc01.jpg | GRAPHIC | 1507677
3 |  | ny20042039x3_nc02.jpg | GRAPHIC | 1024804
| Complete submission text file | 0001140361-25-016010.txt |  | 3493521

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36579 | Film No.: 25880163
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)